Herein, we demonstrate that AIM/CD5L binds to PSA and that a high PSA/AIM ratio, which defines advanced stage PCa (regardless of mutation status), is implicated in enhanced metastability, and is associated with disease recurrence, while a high AIM/PSA ratio is associated with strong castration-induced regression. The gene discussed is CD5L; the disease is posterior cortical atrophy.